1. Show article details.

    Medical Marijuana, Inc.'s RSHO-X Garners FOX 5, Other Global News Coverage After News of Historic Import Permits for Mexican Families

    GlobeNewswire – 9:00 AM ET 02/12/2016

    As reported by multiple Mexico and U.S.-based news agencies, the country of Mexico is embracing the ability of its residents to access, import and use cannabidiol hemp oil in the form of Real Scientific Hemp Oil-X™. “We are extremely pleased to share the latest news reports about CBD hemp oil — specifically RSHO-X™ — with our shareholders, the public and those who are interested in learning abo...

  2. Show article details.

    Medical Marijuana, Inc.'s CEO on Union Tribune Radio Discussing International Cannabis Law Changes, US Cannabis Exports: RSHO and RSHO-X Cannabidiol (CBD) Products

    GlobeNewswire – 9:00 AM ET 02/11/2016

    The world has benefited from life-changing discoveries and resulting innovations. These all-natural cannabis products contain an abundance of cannabidiol, a cannabinoid or component of the plant.

  3. Show article details.

    Medical Marijuana Inc.’s CEO Delivers Historic Keynote Address on Cannabidiol (CBD) at VII Mexico City World Anti-Aging Congress

    GlobeNewswire – 11:30 AM ET 02/10/2016

    Medical Marijuana, Inc. (MJNA) is pleased to inform shareholders and the general public that the Company’s Chief Executive Officer, Dr. Stuart W. Titus, will deliver a historic keynote address on cannabidiol at the VII Mexico City World Anti-Aging Congress on February 13th. The global healthcare conference takes place February 12th – 14th at the Hotel Fiesta Americana Reforma, Mexico City.

  4. Show article details.

    Medical Marijuana, Inc.'s HempMeds® México Ships RSHO-X, First-Ever Federally Approved Cannabidiol (CBD) Product February 8

    GlobeNewswire – 9:00 AM ET 02/05/2016

    HempMeds® Mexico is the sales, marketing and distribution company for the first cannabidiol hemp oil product granted special permission by the Mexican government for import. This historic decision now makes HempMeds® Mexico’s RSHO-XTM product available for use nationwide. In the U.S., CBD hemp oil products are considered a “nutritional supplement” or “food product.

  5. Show article details.

    Medical Marijuana, Inc. Announces the Launch of HempMeds® Mexico: Opening the Cannabidiol (CBD) Market to the Country’s More Than 122 Million Residents

    GlobeNewswire – 1:30 PM ET 02/04/2016

    Medical Marijuana (MJNA), Inc.’s RSHO-XTM Hemp-Based Cannabidiol Products Are Now Available For Import Into Mexico at HempMeds.MX It is with great excitement that Medical Marijuana (MJNA), Inc. announces the launch of HempMeds® Mexico to shareholders and the public. “The Company is in the process of establishing a HempMeds® Mexico office in Monterrey, Mexico within the next week.

  6. Show article details.

    Medical Marijuana, Inc. Featured by Reuters: Mexico Government Grants Import of RSHO-X, Market Estimated $1-2 Billion for CBD Hemp Oil Over 10 Years

    GlobeNewswire – 9:00 AM ET 02/04/2016

    Medical Marijuana (MJNA), Inc.’s is proud to inform shareholders and the public that Reuters wire news agency featured the Company in the article California-based Medical Marijuana Eyes Mexico as Next Big Market. In an historic move, the government of Mexico issued two of the country’s first permits to import a cannabidiol product, RSHO-X, from the U.S. headquartered industrial hemp company.

  7. Show article details.

    Medical Marijuana, Inc. Celebrates Mexico’s Access to RSHO-X Cannabidiol (CBD) Hemp Oil; Historic Occasion Results in Global News Coverage

    GlobeNewswire – 9:00 AM ET 02/03/2016

    It took him more than eight hours travel by bus to get to Mexico City. Photos accompanying this release are available at. http://www.globenewswire.com/NewsRoom/AttachmentNg/ed83b863-d146-4972-90d1-31a763bb30fa. http://www.globenewswire.com/NewsRoom/AttachmentNg/a71f4c6b-95d1-4524-bf49-8a1565d4a5d1.

  8. Show article details.

    Medical Marijuana, Inc.’s RSHO-X: Government of Mexico Approves Historic First Import Permits for Cannabidiol (CBD) Oil – Permits Now Available Via COFEPRIS

    GlobeNewswire – 2:36 PM ET 02/02/2016

    Medical Marijuana (MJNA), Inc.’s is proud to inform shareholders and the public that today the Health Department of Mexico, COFEPRIS, issued the country’s first-ever government permits to import cannabidiol hemp oil.

  9. Show article details.

    California-based Medical Marijuana eyes Mexico as next big market

    Reuters – 12:13 PM ET 02/02/2016

    Medical Marijuana Inc (MJNA), a pioneer in the industrial hemp business, is betting on Mexico as its next big market as the country opens up to the import of some cannabis-derived products for medical use. The California-based company manufactures a hemp oil which can, under permits granted this week, be imported to Mexico for the first time to treat specific medical cases.

  10. Show article details.

    Medical Marijuana, Inc. Sponsors “Por Grace Foundation’s” CBD Hemp Oil Awareness Events in Mexico

    GlobeNewswire – 11:25 AM ET 01/21/2016

    Medical Marijuana (MJNA), Inc.  is proud to announce its support of a cannabidiol hemp oil educational event Sunday, January 24, 2016 in Mexico City, hosted by our premier charitable partner, the “Por Grace Foundation. The cannabis movement is quickly progressing in Mexico starting with Congressional hearings set to begin on Monday, January 25th.

  11. Show article details.

    MJNA Announces $14 Million Debt Reduction and Major Strategic Acquisitions in the Fourth Quarter of 2015

    GlobeNewswire – 9:10 AM ET 01/14/2016

    Medical Marijuana (MJNA), Inc.  is pleased to announce the Company has significantly reduced its debt obligation from $24 million at the close of the third quarter to approximately $10 million at the close of the fourth quarter, a reduction of approximately $14 million.

  12. Show article details.

    Medical Marijuana, Inc. Announces $14 Million Debt Reduction and Major Strategic Acquisitions in the Fourth Quarter of 2015

    GlobeNewswire – 9:10 AM ET 01/13/2016

    Medical Marijuana, Inc. (MJNA) is pleased to announce the Company has significantly reduced its debt obligation from $24 million at the close of the third quarter to approximately $10 million at the close of the fourth quarter, a reduction of approximately $14 million.

  13. Show article details.

    Medical Marijuana, Inc. Investment – AXIM Biotech – Featured by Reuters; Cannabis "Gum to Treat Multiple Sclerosis" Pain and Spasticity

    GlobeNewswire – 9:00 AM ET 01/06/2016

    Medical Marijuana, Inc. (MJNA) is proud to announce to the public and its shareholders that its portfolio investment, AXIM® Biotechnologies, Inc., was recently featured in a Health article by Reuters global news agency.

  14. Show article details.

    Medical Marijuana, Inc. CEO Discusses Real Scientific Hemp Oil™ and Expanding Foreign Markets on TheStockRadio.com

    GlobeNewswire – 9:00 AM ET 01/05/2016

    Medical Marijuana, Inc. (MJNA) and TheStockRadio.com, Inc. announced today that a new interview with Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, is now available.

  15. Show article details.

    MJNA’s Kannaway on Forbes Magazine’s Holiday List: Top 5 Christmas Cannabis Gifts

    GlobeNewswire – 9:00 AM ET 12/23/2015

    Forbes, a globally recognized and influential publication, is well known for its lists that include rankings of: individual wealth, companies, people, educational institutions and more. In the Forbes list is Medical Marijuana (MJNA), Inc.’s award-winning portfolio company, Kannaway, LLC, and their Cannabis Beauty DEFINED™ products.

  16. Show article details.

    Medical Marijuana, Inc. and Kannalife Sciences, Inc. Announce Joint Effort to Raise Awareness for CTE Research

    GlobeNewswire – 1:57 PM ET 12/22/2015

    Medical Marijuana, Inc. (MJNA) is proud to announce to shareholders and the public a joint effort with investment portfolio company Kannalife Sciences, Inc. to open an opportunity for the public to “show their green” and participate in a fundraiser for research driven by Kannalife at Temple University for the potential use of cannabidiol as a treatment for chronic traumatic encephalopathy.

  17. Show article details.

    Medical Marijuana, Inc.’s Portfolio Company KannaLife’s Spokesman, Ex-NFL Star Marvin Washington to Appear on ESPN’s Outside the Lines

    GlobeNewswire – 9:00 AM ET 12/18/2015

    Medical Marijuana, Inc. (MJNA) is proud to announce to shareholders and the public that investment portfolio company KannaLife Sciences’ spokesman and former NFL star Marvin Washington will be appearing on ESPN’s Outside the Lines Friday, December 18, from 2:30pm-3pm ET.

  18. Show article details.

    Medical Marijuana, Inc.’s HempMeds Brasil™ Now Has Three Medical Indications Approved as Prescriptions – 100% of the Costs Now Covered by Brazilian Government

    GlobeNewswire – 9:00 AM ET 12/14/2015

    Medical Marijuana (MJNA), Inc.’s cannabidiol hemp oil – a legal U.S. cannabis product shipping to all 50 states – is creating global demand and a new business category for export.

  19. Show article details.

    Retired NFL Star Marvin Washington Leads the Charge in "Show Your Green" – A Kannalife and Medical Marijuana, Inc. PSA and Awareness Campaign for CTE Research

    GlobeNewswire – 9:00 AM ET 12/10/2015

    To address the public’s questions about CTE, what the disease is and who it impacts — Medical Marijuana, Inc. (MJNA) and its portfolio company Kannalife Sciences, Inc. and phyto-medical company involved in the research and development of novel therapeutic agents designed to be neuroprotectants and immuno-modulators — are responding with a social media-driven campaign titled “Show Your Green.

  20. Show article details.

    Chronic Pain: Third Indication Approved by Brazilian Government for Medical Marijuana Inc.’s Real Scientific Hemp Oil™ (RSHO™)

    GlobeNewswire – 9:53 AM ET 12/08/2015

    Medical Marijuana, Inc. (MJNA) is pleased to announce to the public and its shareholders that the government of Brazil has approved chronic pain as a third indication for import of the Company’s cannabidiol hemp oil product Real Scientific Hemp Oil™. As seen on ABC 7 News, the first two indications to be approved for the import of RSHO™ by the Brazilian government are epilepsy and Parkinson’s disease.

Page:

Today's and Upcoming Events

No events in the next 90 days

Past Events (last 90 days)

No events in the past 90 days

Data provided by Wall Street Horizon, Inc. © 2016

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.